Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Clark

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Science (New York, N.Y.)|October 7, 2006
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisManuela Neumann, Deepak M Sampathu, Linda K Kwong, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2016
Conditional vulnerability of plant diversity to atmospheric nitrogen deposition across the United StatesSamuel M Simkin, Edith B Allen, William D Bowman, et al.
Neurobiology of Aging|May 29, 2012
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer diseaseAdam S Fleisher, Kewei Chen, Xiaofen Liu, et al.
The Lancet. Neurology|July 4, 2012
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort studyChristopher M Clark, Michael J Pontecorvo, Thomas G Beach, et al.
Acta Neuropathologica|July 27, 2007
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseasesHanae Nakashima-Yasuda, Kunihiro Uryu, John Robinson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2013
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal agingKeith A Johnson, Reisa A Sperling, Christopher M Gidicsin, et al.
Environmental Science & Technology|December 15, 2025
The US EPA's National Nutrient Inventory: Critical Shifts in US Nutrient Pollution Sources from 1987 to 2017Meredith M Brehob, Michael J Pennino, Jana E Compton, et al.
Archives of Neurology|December 15, 2010
Validation of consensus panel diagnosis in dementiaMatthew J Gabel, Norman L Foster, Judith L Heidebrink, et al.
JAMA|January 20, 2011
Use of florbetapir-PET for imaging beta-amyloid pathologyChristopher M Clark, Julie A Schneider, Barry J Bedell, et al.
Journal of Neuropathology and Experimental Neurology|December 17, 2013
Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlatesBrittany N Dugger, Christopher M Clark, Geidy Serrano, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Science (New York, N.Y.)|October 7, 2006
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisManuela Neumann, Deepak M Sampathu, Linda K Kwong, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2016
Conditional vulnerability of plant diversity to atmospheric nitrogen deposition across the United StatesSamuel M Simkin, Edith B Allen, William D Bowman, et al.
Neurobiology of Aging|May 29, 2012
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer diseaseAdam S Fleisher, Kewei Chen, Xiaofen Liu, et al.
The Lancet. Neurology|July 4, 2012
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort studyChristopher M Clark, Michael J Pontecorvo, Thomas G Beach, et al.
Acta Neuropathologica|July 27, 2007
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseasesHanae Nakashima-Yasuda, Kunihiro Uryu, John Robinson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2013
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal agingKeith A Johnson, Reisa A Sperling, Christopher M Gidicsin, et al.
Environmental Science & Technology|December 15, 2025
The US EPA's National Nutrient Inventory: Critical Shifts in US Nutrient Pollution Sources from 1987 to 2017Meredith M Brehob, Michael J Pennino, Jana E Compton, et al.
Archives of Neurology|December 15, 2010
Validation of consensus panel diagnosis in dementiaMatthew J Gabel, Norman L Foster, Judith L Heidebrink, et al.
JAMA|January 20, 2011
Use of florbetapir-PET for imaging beta-amyloid pathologyChristopher M Clark, Julie A Schneider, Barry J Bedell, et al.
Journal of Neuropathology and Experimental Neurology|December 17, 2013
Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlatesBrittany N Dugger, Christopher M Clark, Geidy Serrano, et al.
Pageof 14